WKN: | A1W7D4 |
ISIN: | CA05156V1022 |
Land: | Kanada |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Pharma |
Weshalb die Aurinia Pharmaceuticals-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 08. August 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2013 | 0,3000 | 2,3900 | 696,67% |
2 | 2019 | 5,1600 | 18,5000 | 258,53% |
3 | 2010 | 2,8000 | 7,4500 | 166,07% |
4 | 2023 | 3,4300 | 8,1900 | 138,78% |
5 | 2009 | 1,2500 | 2,8000 | 124,00% |
6 | 2017 | 1,9800 | 3,7600 | 89,90% |
7 | 2021 | 11,1000 | 19,7700 | 78,11% |
8 | 2018 | 3,7600 | 5,1600 | 37,23% |
9 | 2014 | 2,3900 | 2,8800 | 20,50% |
10 | 2025 | 8,6200 | 9,8500 | 14,27% |
11 | 2005 | 63,0000 | 68,5000 | 8,73% |
12 | 2024 | 8,1900 | 8,6200 | 5,25% |
13 | 2003 | 92,5000 | 87,5000 | -5,41% |
14 | 2016 | 2,3100 | 1,9800 | -14,29% |
15 | 2015 | 2,8800 | 2,3100 | -19,79% |
16 | 2006 | 68,5000 | 53,5000 | -21,90% |
17 | 2004 | 87,5000 | 63,0000 | -28,00% |
18 | 2020 | 18,5000 | 11,1000 | -40,00% |
19 | 2007 | 53,5000 | 30,2000 | -43,55% |
20 | 2002 | 165,0000 | 92,5000 | -43,94% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2008 | 30,2000 | 1,2500 | -95,86% |
2 | 2012 | 2,1500 | 0,3000 | -86,05% |
3 | 2022 | 19,7700 | 3,4300 | -82,65% |
4 | 2011 | 7,4500 | 2,1500 | -71,14% |
5 | 2002 | 165,0000 | 92,5000 | -43,94% |
6 | 2007 | 53,5000 | 30,2000 | -43,55% |
7 | 2020 | 18,5000 | 11,1000 | -40,00% |
8 | 2004 | 87,5000 | 63,0000 | -28,00% |
9 | 2006 | 68,5000 | 53,5000 | -21,90% |
10 | 2015 | 2,8800 | 2,3100 | -19,79% |
11 | 2016 | 2,3100 | 1,9800 | -14,29% |
12 | 2003 | 92,5000 | 87,5000 | -5,41% |
13 | 2024 | 8,1900 | 8,6200 | 5,25% |
14 | 2005 | 63,0000 | 68,5000 | 8,73% |
15 | 2025 | 8,6200 | 9,8500 | 14,27% |
16 | 2014 | 2,3900 | 2,8800 | 20,50% |
17 | 2018 | 3,7600 | 5,1600 | 37,23% |
18 | 2021 | 11,1000 | 19,7700 | 78,11% |
19 | 2017 | 1,9800 | 3,7600 | 89,90% |
20 | 2009 | 1,2500 | 2,8000 | 124,00% |